The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Promab Biotechnologies

  • Contact Person: John Wu
  • Contact Phone: 510-860-4615
  • Contact Email: john@promab.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Industries Served:
  • Product Areas: IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS, IN VITRO DIAGNO SUBSTANCES,REAGENTS, STUDY/CHEMICAL-BIOLOGICAL, SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $9,600 - Friday the 7th of February 2014
    Food And Drug Administration
    DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
    IGF::OT::IGF "OTHER FUNCTION" MONOCLONAL ANTIBODY PRODUCTION
  • $19,540 - Thursday the 8th of December 2011
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    MK1571101/WENDY MARRINER/PROMAB

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.